Demailly P, Jeanteur-Lunel M N, Berkani M, Ecoffet M, Kopel J, Kretz G, Lavat P
Institut du Glaucome, Fondation Hôpital Saint-Joseph, Paris.
J Fr Ophtalmol. 1996;19(11):659-66.
To evaluate the middle term tonometric results of a new filtering procedure, the non penetrating deep sclerectomy with collagen device, in primary open-angle glaucoma. This technique aims to eliminate or minimize the complications of classical trabeculectomy.
This procedure has been developed by Koslov et al. Under a limbal-base conjunctival flap and a superficial scleral flap, the ablation of a deep scleral flap takes away the external wall of Schlemm's canal, leaving only the Descemet membrane. A visible filtration across the opened Schlemm's canal and Descemet membrane is obtained. To improve the aqueous filtration, a cylindric collagen device, made from biocompatible porcine scleral tissue, known for its high water content, is fixed in the deep scleral bed with a 10/0 nylon suture. This device provides a support for the elimination route of aqueous humor and acts like a sponge, carrying the liquid by capillary action. It is sterilized by irradiation. Full guarantee against viral contamination is provided. This procedure ends in one suture (40/0 nylon) of superficial scleral flap and conjunctival closing suture. We conducted a retrospective study. Our material included 159 patients (92 males, 65 females), 2/9 eyes. The mean age was 65 years (11-91). The mean follow-up : 8 months (3-20). The types of glaucoma were: POAG: 183 eyes; juvenile POAG: 18 eyes: pigmentary glaucoma: 11 eyes; capsular glaucoma: 7 eyes, 58 eyes (40 patients) presented one or several risk factors of failure for filtering surgery.
The mean pre-operative IOP was 24 mmHg +/- 6.60; 15.7 +/- 5.30 at the end of the follow-up (delta average IOP: 9.1 +/- 7.1). The probability success rate (IOP < or = 20 mmHg), according to the Kaplan-Meier Method, was 89% at six months, 75.6% at 16 months. With monotherapy with beta blockers, 79% at 16 months. It was better in the without risk factors group. The mean change in visual acuity was inferior to 0.1 at the end of the follow-up. Except several hyphemas, no complications of the trabeculectomy were observed. The reelevation of IOP was due to an internal obstruction (goniosynechiae or bad filtration), it was treated with Nd-Yag laser with a 2/3 of success rate. External obstruction was treated by 5FU injections into the bleb.
Non penetrating deep sclerectomy with collagen device can be an excellent alternative to trabeculectomy in open and wide angles. It does not modify visual actuity. It carries less complications than trabeculectomy and the use of antimitotic agents is safer.
评估一种新的滤过手术——使用胶原装置的非穿透性深层巩膜切除术,用于原发性开角型青光眼的中期眼压测量结果。该技术旨在消除或减少经典小梁切除术的并发症。
此手术由科斯洛夫等人研发。在角膜缘基底结膜瓣和浅层巩膜瓣下,切除深层巩膜瓣以去除施莱姆管的外壁,仅留下Descemet膜。通过开放的施莱姆管和Descemet膜可实现可见的滤过。为改善房水滤过,将由生物相容性猪巩膜组织制成、以高含水量著称的圆柱形胶原装置,用10/0尼龙缝线固定在深层巩膜床中。该装置为房水的排出途径提供支撑,起到海绵的作用,通过毛细作用输送液体。它经辐射灭菌。可完全保证防止病毒污染。此手术以缝合一层浅层巩膜瓣(40/0尼龙缝线)和结膜闭合缝线结束。我们进行了一项回顾性研究。我们的研究对象包括159例患者(92例男性,65例女性),共299只眼。平均年龄为65岁(11 - 91岁)。平均随访时间:8个月(3 - 20个月)。青光眼类型包括:原发性开角型青光眼:183只眼;青少年原发性开角型青光眼:18只眼;色素性青光眼:11只眼;晶状体囊膜性青光眼:7只眼,58只眼(40例患者)存在一项或多项滤过手术失败的危险因素。
术前平均眼压为24 mmHg ± 6.60;随访结束时为15.7 ± 5.30(眼压平均下降值:9.1 ± 7.1)。根据Kaplan - Meier法,概率成功率(眼压≤20 mmHg)在6个月时为89%,16个月时为75.6%。使用β受体阻滞剂单一疗法时,16个月时为79%。在无危险因素组中效果更好。随访结束时视力平均变化小于0.1。除了几例前房积血外,未观察到小梁切除术的并发症。眼压再次升高是由于内部阻塞(房角粘连或滤过不良),用Nd - Yag激光治疗,成功率为2/3。外部阻塞通过向滤过泡内注射5 - 氟尿嘧啶治疗。
使用胶原装置的非穿透性深层巩膜切除术在开角型青光眼治疗中可成为小梁切除术的极佳替代方法。它不改变视力。与小梁切除术相比,并发症更少,且抗有丝分裂剂的使用更安全。